UPDATE 1-FDA warns Abbott over diagnostics manufacturing

steps to address problems (Adds Abbott comment, background) WASHINGTON, Nov 17 (Reuters) - U.S. regulators have warned Abbott Laboratories Inc (ABT.N) about poor manufacturing standards at a molecular diagnostics plant. The U.S. Food and Drug...